[go: up one dir, main page]

MX380802B - Un proceso de etapas múltiples para la producción de no. - Google Patents

Un proceso de etapas múltiples para la producción de no.

Info

Publication number
MX380802B
MX380802B MX2017013601A MX2017013601A MX380802B MX 380802 B MX380802 B MX 380802B MX 2017013601 A MX2017013601 A MX 2017013601A MX 2017013601 A MX2017013601 A MX 2017013601A MX 380802 B MX380802 B MX 380802B
Authority
MX
Mexico
Prior art keywords
production
stage process
relates
labile
donor
Prior art date
Application number
MX2017013601A
Other languages
English (en)
Other versions
MX2017013601A (es
Inventor
Annahit Arshi
Christian Schulze
Karsten Hemmrich
Original Assignee
Bsn Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bsn Medical Gmbh filed Critical Bsn Medical Gmbh
Publication of MX2017013601A publication Critical patent/MX2017013601A/es
Publication of MX380802B publication Critical patent/MX380802B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B21/00—Nitrogen; Compounds thereof
    • C01B21/20—Nitrogen oxides; Oxyacids of nitrogen; Salts thereof
    • C01B21/24—Nitric oxide (NO)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

La presente invención se refiere a un procedimiento de múltiples etapas para producir óxido nítrico (NO) a partir de un donador de NO lábil al pH en presencia de al menos un antioxidante. La invención se refiere también a un dispositivo para llevar a cabo este procedimiento y al uso de este dispositivo para el tratamiento de enfermedades. Además, la invención se refiere a un procedimiento cosmético que usa el procedimiento o el dispositivo.
MX2017013601A 2015-04-29 2016-04-26 Un proceso de etapas múltiples para la producción de no. MX380802B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15165747 2015-04-29
PCT/EP2016/059312 WO2016174043A1 (de) 2015-04-29 2016-04-26 Mehrstufiges verfahren zur no-herstellung

Publications (2)

Publication Number Publication Date
MX2017013601A MX2017013601A (es) 2018-07-06
MX380802B true MX380802B (es) 2025-03-12

Family

ID=53015680

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017013601A MX380802B (es) 2015-04-29 2016-04-26 Un proceso de etapas múltiples para la producción de no.

Country Status (10)

Country Link
US (1) US20180116920A1 (es)
EP (1) EP3288893B8 (es)
JP (1) JP6942058B2 (es)
CN (1) CN107809996A (es)
AU (1) AU2016256186B2 (es)
BR (1) BR112017023057B1 (es)
CA (1) CA2984044A1 (es)
MX (1) MX380802B (es)
WO (1) WO2016174043A1 (es)
ZA (1) ZA201707922B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019209910A1 (en) * 2018-04-25 2019-10-31 Noxsano Inc. Light activated gasotransmitter generating compositions
CN109846113A (zh) * 2018-11-29 2019-06-07 南京诺全生物医疗科技有限公司 一种可自提供一氧化氮的口鼻卫生用品

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA741203B (en) 1973-03-23 1975-01-29 Smithkline Corp Veterinary feed compositions for inhibiting rumen microbial deamination
US4151175A (en) 1976-12-09 1979-04-24 General Electric Company Method for making diarylhalonium salts
US4347372A (en) 1978-09-01 1982-08-31 Ciba-Geigy Corporation Benzoxazolyl-glyoxylonitrile-2-oxime ether derivatives
US4357469A (en) * 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
US4346094A (en) 1980-09-22 1982-08-24 Eli Lilly And Company 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels
US4399071A (en) 1982-03-12 1983-08-16 General Electric Company Method for making diaryliodonium salts
US4540598A (en) 1983-08-17 1985-09-10 Ciba-Geigy Corporation Process for curing acid-curable finishes
US4694029A (en) 1985-04-09 1987-09-15 Cook Paint And Varnish Company Hybrid photocure system
DE3660255D1 (en) 1985-04-12 1988-07-07 Ciba Geigy Ag Oxime sulphonates containing reactive groups
GB8608528D0 (en) 1986-04-08 1986-05-14 Ciba Geigy Ag Production of positive images
EP0361907A3 (en) 1988-09-29 1991-05-02 Hoechst Celanese Corporation Photoresist compositions for deep uv image reversal
US5834445A (en) * 1989-08-11 1998-11-10 Sikorski; Christopher Process for preparing decolorized carotenoid-cyclodextrin complexes
JPH04295458A (ja) 1991-03-22 1992-10-20 Fuji Photo Film Co Ltd 光照射により酸を発生する化合物
FR2688783A1 (fr) 1992-03-23 1993-09-24 Rhone Poulenc Chimie Nouveaux borates d'onium ou de complexe organometallique amorceurs cationiques de polymerisation.
DE59309494D1 (de) 1992-05-22 1999-05-12 Ciba Geigy Ag Hochauflösender I-Linien Photoresist mit höherer Empfindlichkeit
CA2163875A1 (en) 1993-05-26 1994-12-08 Huig Klinkenberg Coating composition including a uv-deblockable basic catalyst
MY132867A (en) 1995-11-24 2007-10-31 Ciba Specialty Chemicals Holding Inc Acid-stable borates for photopolymerization
JP3587413B2 (ja) 1995-12-20 2004-11-10 東京応化工業株式会社 化学増幅型レジスト組成物及びそれに用いる酸発生剤
EP0882072B2 (en) 1996-02-22 2005-10-26 Ciba SC Holding AG Anionic photocatalyst
EP0971924B1 (en) 1997-01-22 2002-08-21 Ciba SC Holding AG Photoactivatable nitrogen-containing bases based on alpha-amino ketones
KR100542419B1 (ko) 1997-02-26 2006-01-11 시바 스페셜티 케미칼스 홀딩 인크. α-암모늄 케톤, 이미늄 케톤 또는 아미디늄 케톤 및 아릴 보레이트계의 광활성화 가능한 질소 함유 염기, 이의 제조방법 및 이를 포함하는 조성물
KR100527614B1 (ko) 1997-03-18 2005-11-15 시바 스페셜티 케미칼스 홀딩 인크. α-아미노 알켄 화합물, 이의 제조방법 및 당해 화합물을 포함하는 조성물
FR2762001B1 (fr) 1997-04-11 1999-07-02 Rhodia Chimie Sa Amorceurs non toxiques, resines a groupements organofonctionnels reticulables comprenant les amorceurs, et leur utilisation pour la preparation de polymeres stables et non toxiques
EP0898202B1 (en) 1997-08-22 2000-07-19 Ciba SC Holding AG Photogeneration of amines from alpha-aminoacetophenones
US6060324A (en) * 1997-11-12 2000-05-09 Phytochem Technologies, Inc. Fluorometric assay composition for measurement of antioxidant activity
DE19828614A1 (de) 1998-06-26 1999-12-30 Ams Optotech Vertrieb Gmbh Verfahren und Vorrichtung zur optischen Datenübertragung über Lichtwellenleiter
WO2000010964A1 (de) 1998-08-21 2000-03-02 Ciba Specialty Chemicals Holding Inc. Photoaktivierbare stickstoffhaltige basen
KR100634037B1 (ko) 1998-10-29 2006-10-17 시바 스페셜티 케미칼스 홀딩 인크. 옥심 유도체, 이의 제조방법 및 이를 포함하는 조성물
SG78412A1 (en) 1999-03-31 2001-02-20 Ciba Sc Holding Ag Oxime derivatives and the use thereof as latent acids
RU2265035C2 (ru) 2000-05-26 2005-11-27 Акцо Нобель Н.В. Фотоактивируемая композиция покрытия
GB0114266D0 (en) 2001-06-12 2001-08-01 Ciba Sc Holding Ag Laser marking method
WO2003006427A1 (en) 2001-07-12 2003-01-23 Johns Hopkins University Compounds that release nitric oxide at controlled rates upon photolysis
US6673338B1 (en) 2001-09-10 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
EP1436297B1 (en) 2001-10-17 2007-04-25 Ciba Specialty Chemicals Holding Inc. Photoactivable nitrogen bases
AU2002230733A1 (en) 2001-12-10 2003-06-23 Em-Tech Llc Apparatus and method for measuring induced resistivity of a material within a confined space as in a down-hole hydrocarbon production well using separate lens segments around the transmitter
US20030039697A1 (en) 2002-09-12 2003-02-27 Yi-Ju Zhao Matrices containing nitric oxide donors and reducing agents and their use
EP1751220A1 (en) 2004-04-07 2007-02-14 CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement Method of coloring a coating composition
DE602006006432D1 (de) * 2005-03-24 2009-06-04 Nolabs Ab Kosmetische behandlung mit stickoxid, vorrichtung zur durchführung dieser behandlung und herstellungsverfahren dafür
EP1903003B1 (de) 2006-07-05 2017-07-05 BSN medical GmbH Verfahren zur photolytischen Erzeugung von Stickstoffmonoxid
EP2051935B1 (en) 2006-07-26 2016-09-07 STMicroelectronics Srl Use of nitroaniline derivatives for the production of nitric oxide
KR101538727B1 (ko) * 2006-10-05 2015-07-22 이카리아 인코포레이티드 액체 칼코게나이드 조성물 및 이의 제조방법과 사용방법
US8685467B2 (en) * 2010-08-03 2014-04-01 J. W. Randolph Miller Nitric oxide generation, dilution, and topical application apparatus and method
JP2014501578A (ja) * 2010-12-03 2014-01-23 コーニンクレッカ フィリップス エヌ ヴェ 一酸化窒素の生成方法及び装置
US9669041B2 (en) * 2011-10-27 2017-06-06 Novan, Inc. Nitric oxide releasing bath compositions and methods of using the same
US20130330244A1 (en) * 2011-12-05 2013-12-12 Nioxx Llc Compositions and methods for topical nitric oxide generation
US10517817B2 (en) * 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method

Also Published As

Publication number Publication date
AU2016256186A1 (en) 2017-12-07
EP3288893B8 (de) 2019-04-10
MX2017013601A (es) 2018-07-06
JP6942058B2 (ja) 2021-09-29
BR112017023057B1 (pt) 2023-03-28
AU2016256186B2 (en) 2020-01-16
BR112017023057A2 (pt) 2018-07-03
CN107809996A (zh) 2018-03-16
ZA201707922B (en) 2018-11-28
US20180116920A1 (en) 2018-05-03
WO2016174043A1 (de) 2016-11-03
JP2018515415A (ja) 2018-06-14
EP3288893B1 (de) 2019-02-27
CA2984044A1 (en) 2016-11-03
EP3288893A1 (de) 2018-03-07

Similar Documents

Publication Publication Date Title
SA519401522B1 (ar) Lag-3 أجـسـام مـضـادة لـ وتـركـيـبـات
JOP20200192A1 (ar) أجسام مضادة لـ tigit
ZA201705114B (en) Cysteine protease
ZA201705113B (en) Cysteine protease
HUE043531T2 (hu) Kezelési eljárás nemes-, nem nemes- és ritkafémek kivonására
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
CO2017004314A2 (es) Compuestos anti-tnf
PH12016502586A1 (en) Lipid comprising docosapentaenoic acid
EA201890185A1 (ru) Способы лечения опосредованных гепсидином нарушений
DK3142785T3 (da) Fremgangsmåde til fremstilling af alkenoler og anvendelse deraf til fremstilling af 1,3-butadien
PH12018500578A1 (en) Methods of treating inflammatory diseases
EA201792157A1 (ru) Имидазопиразиноны в качестве ингибиторов pde1
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
MX370628B (es) Composiciones y metodos para tratar las espinillas.
EA201790312A1 (ru) Комбинации лекарственных средств для лечения множественной миеломы
MX2017007000A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
MX2017000467A (es) Nuevo proceso para la purificacion de rhu-gcsf.
CL2018000009A1 (es) Un proceso para tratar leche
EP3538124A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES, HYPERTENSION AND HYPERCHOLESTEROLEMIA
MX374458B (es) Compuestos de triaminopirimidina útiles para evitar o tratar la malaria.
MX380802B (es) Un proceso de etapas múltiples para la producción de no.
EA201691335A1 (ru) Гексагидрофуропирролы в качестве ингибиторов pde1
MX2019010060A (es) Composiciones y metodo para tratar cancer.
UY37763A (es) 2,5-dibromopiridina y procesos para prepararla
RU2014154366A (ru) Применение пробиотического штамма микроорганизма enterococcus faecium l3 для лечения нейродегенеративных заболеваний